Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

The Prognostic Impact of HMGCLL1 Gene Variant on Treatment Outcomes in Chronic Myeloid Leukemia (CML) Patients: Adverse Impact on the Response, Failure, and Progression with Imatinib Which Can be Abrogated By the Use of 2 nd Generation Tyrosine Kinase Inhibitor (TKI) Upfront Therapy

Blood (2022) 140 (Supplement 1): 6774–6775.

https://doi.org/10.1182/blood-2022-168228

Published: 2022

Journal Articles

Somatic Mutations Are Frequently Detected in CML Patients before Treatment-Free Remission (TFR) Attempt with Tyrosine Kinase Inhibitor (TKI) Discontinuation but with Uncertain Predictive Value for Tfr Failure

Blood (2022) 140 (Supplement 1): 6782–6783.

https://doi.org/10.1182/blood-2022-167927

Published: 2022

Journal Articles

Ocular MALT Lymphoma Free from the Chlamydia Psittaci Infection ; Analysis of 150 Cases

Gyeongsin Park, MD PhD, Hye Won Lee, MD, Uiju Cho, MD, Suk Woo Yang, MD, Seok-Goo Cho, Youn Soo Lee, MD, Chang Suk Kang, MD

Blood (2016) 128 (22): 4139.

https://doi.org/10.1182/blood.V128.22.4139.4139

Published: 2016

Journal Articles

Final Report on Phase II Trial of L-Asparaginase Plus Concurrent Chemoradiotherapy Followed By Midle (Methotrexate, Ifosfamide, Etoposide, Dexamethasone, and L-asparaginase) Chemotherapy for Patients with Newly Diagnosed Stage I/II Extranodal NK/T-Cell Lymphoma, Nasal Type

Dok Hyun Yoon, MD PhD, Seok Jin Kim, MD PhD, Seong Hyun Jeong, MD, Dong-Yeop Shin, MD, Sung Hwa Bae, MD, Junshik Hong, MD, Seong Kyu Park, MD, Ho-Young Yhim, MD, Deok-Hwan Yang, MD, Hye Won Lee, MD, Mark Lee, MD PhD, Hyeonseok Eom, MD, PhD, Jae-Yong Kwak, MD PhD, Jae Hoon Lee, Cheolwon Suh, Won Seog Kim, MD PhD

Blood (2015) 126 (23): 3942.

https://doi.org/10.1182/blood.V126.23.3942.3942

Published: 2015

Journal Articles

Phase II Trial Of L-Asparaginase Plus Concurrent Chemoradiotherapy Followed By Midle (methotrexate, ifosfamide, etoposide, dexamethasone, and L-asparaginase) Chemotherapy For Patients With Newly Diagnosed Stage I/II Extranodal NK/T-Cell Lymphoma, Nasal Type

Seok Jin Kim, MD, PhD, Dok Hyun Yoon, MD, Seong Hyun Jeong, Dong-Yeop Shin, MD, Sung Hwa Bae, Junshik Hong, MD, Eun Kyung Park, Se Hyung Kim, Ho-Young Yhim, MD, Deok-Hwan Yang, MD, Hye Won Lee, Je-Jung Lee, MD, PhD, Mark Lee, MD, PhD, Hyeon Seok Eom, MD, PhD, Jae-Yong Kwak, MD, PhD, Jae Hoon Lee, Dae Sik Hong, Cheolwon Suh, Won Seog Kim

Blood (2013) 122 (21): 3037.

https://doi.org/10.1182/blood.V122.21.3037.3037

Published: 2013

Journal Articles

Pretransplant Parathyroid Hormone Level Has No Correlation with Platelet Recovery After Stem Cell

Soo-Jeong Kim, MD, Yundeok Kim, MD, Shin-Young Hyun, MD, Ji-Eun Jang, MD, Doh Yu Hwang, MD, June-Won Cheong, MD, PhD, Jin Seok Kim, Yu Ri Kim, Hye Won Lee, Yoo-Hong Min, MD, PhD

Blood (2012) 120 (21): 4495.

https://doi.org/10.1182/blood.V120.21.4495.4495

Published: 2012

Journal Articles

High Serum Level of APRIL Is Related to Increased Risk of Acute Gvhd

Soo-Jeong Kim, MD, Yundeok Kim, MD, Shin Young Hyun, Ji Eun Jang, Doh Yu Hwang, MD, Yu Ri Kim, Hye Won Lee, June-Won Cheong, MD, PhD, Jin Seok Kim, Yoo-Hong Min, MD, PhD

Blood (2012) 120 (21): 4161.

https://doi.org/10.1182/blood.V120.21.4161.4161

Published: 2012

Journal Articles

Effects of Prophylactic Defibrotide for Veno-Occlusive Disease in Hematopoietic Stem Cell Transplantation

Meerim Park, Hyeon Jin Park, Hyeon-Seok Eom, Jeong A Park, Yeon Jung Lim, Jong Hyung Yoon, Hye Won Lee, Tak Yun, Byung-Kiu Park

Blood (2011) 118 (21): 4517.

https://doi.org/10.1182/blood.V118.21.4517.4517

Published: 2011

Journal Articles

Level of Myeloperoxidase Expression as a Crucial Determinant of Sensitivity of Myeloid Leukemia Cells to Parthenolide-Induced Apoptosis

Soo Jeong Kim, M.D., Ju In Eom, Hye Won Lee, M.D., Hoi Kyung Jeung, Jin Seok Kim, M.D., Ph.D., Yoo-Hong Min, M.D., Ph.D.

Blood (2008) 112 (11): 2945.

https://doi.org/10.1182/blood.V112.11.2945.2945

Published: 2008

Journal Articles

Aurora Kinase Inhibition Enhances the Chemotherapy-Induced Myeloid Leukemia Cell Death through Different Mechanism According to the Chemotherapeutic Agents

Soo Jeong Kim, M.D., Haeng Im Jung, Hye Won Lee, M.D., Jin Seok Kim, M.D., Ph.D., Yoo-Hong Min, M.D., Ph.D.

Blood (2008) 112 (11): 2644.

https://doi.org/10.1182/blood.V112.11.2644.2644

Published: 2008

Journal Articles

mTOR Inhibitor Rapamycin Interacts Synergistically with Farnesyltransferase Inhibitor FTI-277 To Induce Growth Inhibition in Human Leukemia Cells.

June-Won Cheong, MD, PhD, Ju In Eom Eom, Hye Won Lee, M.D., In-Hae Park, M.D., Yuri Kim, M.D., Jin Seok Kim, M.D., Ph.D., Yoo-Hong Min, M.D., Ph.D.

Blood (2007) 110 (11): 1821.

https://doi.org/10.1182/blood.V110.11.1821.1821

Published: 2007

Journal Articles

Serum Ferritin Is an Independent Predictive Marker for Stem Cell Mobilization Efficacy in Patients with Hematologic Malignancy.

Soo-Jeong Kim, MD, Hye Won Lee, MD, Sul Hee Yoon, MD, In-Hae Park, MD, Yuri Kim, MD, Jin Seok Kim, MD,PhD, June-Won Cheong, MD, Yoo-Hong Min, MD,PhD

Blood (2006) 108 (11): 5444.

https://doi.org/10.1182/blood.V108.11.5444.5444

Published: 2006

Journal Articles

A Pilot Study of Alemtuzumab Plus Combination Chemotherapy for Newly Diagnosed Patients with Peripheral T-Cell Lymphomas.

Jin Seok Kim, MD, PhD, Soo-Jeong Kim, MD, Hye Won Lee, MD, Sul Hee Yoon, MD, In-Hae Park, MD, Yuri Kim, MD, June-Won Cheong, MD, Yoo-Hong Min, MD,PhD

Blood (2006) 108 (11): 4717.

https://doi.org/10.1182/blood.V108.11.4717.4717

Published: 2006

NARROW

The Prognostic Impact of HMGCLL1 Gene Variant on Treatment Outcomes in Chronic Myeloid Leukemia (CML) Patients: Adverse Impact on the Response, Failure, and Progression with Imatinib Which Can be Abrogated By the Use of 2 nd Generation Tyrosine Kinase Inhibitor (TKI) Upfront Therapy

Somatic Mutations Are Frequently Detected in CML Patients before Treatment-Free Remission (TFR) Attempt with Tyrosine Kinase Inhibitor (TKI) Discontinuation but with Uncertain Predictive Value for Tfr Failure

Ocular MALT Lymphoma Free from the Chlamydia Psittaci Infection ; Analysis of 150 Cases

Final Report on Phase II Trial of L-Asparaginase Plus Concurrent Chemoradiotherapy Followed By Midle (Methotrexate, Ifosfamide, Etoposide, Dexamethasone, and L-asparaginase) Chemotherapy for Patients with Newly Diagnosed Stage I/II Extranodal NK/T-Cell Lymphoma, Nasal Type

Phase II Trial Of L-Asparaginase Plus Concurrent Chemoradiotherapy Followed By Midle (methotrexate, ifosfamide, etoposide, dexamethasone, and L-asparaginase) Chemotherapy For Patients With Newly Diagnosed Stage I/II Extranodal NK/T-Cell Lymphoma, Nasal Type

Pretransplant Parathyroid Hormone Level Has No Correlation with Platelet Recovery After Stem Cell

High Serum Level of APRIL Is Related to Increased Risk of Acute Gvhd

Effects of Prophylactic Defibrotide for Veno-Occlusive Disease in Hematopoietic Stem Cell Transplantation

Level of Myeloperoxidase Expression as a Crucial Determinant of Sensitivity of Myeloid Leukemia Cells to Parthenolide-Induced Apoptosis

Aurora Kinase Inhibition Enhances the Chemotherapy-Induced Myeloid Leukemia Cell Death through Different Mechanism According to the Chemotherapeutic Agents

mTOR Inhibitor Rapamycin Interacts Synergistically with Farnesyltransferase Inhibitor FTI-277 To Induce Growth Inhibition in Human Leukemia Cells.

Serum Ferritin Is an Independent Predictive Marker for Stem Cell Mobilization Efficacy in Patients with Hematologic Malignancy.

A Pilot Study of Alemtuzumab Plus Combination Chemotherapy for Newly Diagnosed Patients with Peripheral T-Cell Lymphomas.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only